SCHEMBL12522012

SCHEMBL12522012

CCCCC(=O)N(C)C(=O)CCCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
CES1 P23141 6/20 0.52
CES2 O00748 5/20 0.52
TP53 P04637 1/20 0.48
CA1 P00915 1/20 0.46
LMNA P02545 1/20 0.46
KDM5A P29375 3/20 0.42
KDM4C Q9H3R0 3/20 0.42
AKR1B1 P15121 1/20 0.42
KDM5C P41229 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
PPARG P37231 3/20 0.40
PPARD Q03181 3/20 0.40
PPARA Q07869 3/20 0.40
TSHR P16473 2/20 0.40
GPR84 Q9NQS5 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11308893 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL2022809 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL13715021 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL19457415 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL13715261 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL13715260 0.90 ALDH1A1 (0.58) ALDH1A1CES1CES2AKR1B1PPARG
SCHEMBL14533776 0.85 ALDH1A1 (0.54) ALDH1A1CES1CES2KDM5AKDM4C
SCHEMBL9210592 0.83
SCHEMBL827843 0.83
SCHEMBL14032784 0.82 ALDH1A1 (0.48) ALDH1A1CES1CES2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9085659-B2 Polymer derivatives comprising an imide branching point NEKTAR THERAPEUTICS (US) 2015-07-21 US disclosed
US-20120238640-A9 Polymer Derivatives Comprising an Imide Branching Point NEKTAR THERAPEUTICS 2012-09-20 US disclosed
US-20080319091-A1 Polymer Derivatives Comprising an Imide Branching Point NEKTAR THERAPEUTICS AL, CORPORATION 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238640-A9 Polymer Derivatives Comprising an Imide Branching Point INCENP, ILK, PIM3 ALDH1A1 1949/4885CES1 2413/4885CES2 2528/4885
US-20080319091-A1 Polymer Derivatives Comprising an Imide Branching Point INCENP, ILK, PIM3 ALDH1A1 1949/4885CES1 2413/4885CES2 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.